Tarsus Pharmaceuticals Inc (NASDAQ: TARS) is 120.89% higher on its value in year-to-date trading and has touched a low of $13.69 and a high of $46.71 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TARS stock was last observed hovering at around $43.87 in the last trading session, with the day’s gains setting it 0.86%.
Currently trading at $44.73, the stock is 20.18% and 35.01% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 1.96% at the moment leaves the stock 41.73% off its SMA200. TARS registered 216.78% gain for a year compared to 6-month loss of 37.67%. The firm has a 50-day simple moving average (SMA 50) of $33.1302 and a 200-day simple moving average (SMA200) of $31.560675.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 38.53% gain in the last 1 month and extending the period to 3 months gives it a 90.91%, and is 14.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.11% over the week and 5.46% over the month.
Tarsus Pharmaceuticals Inc (TARS) has around 244 employees, a market worth around $1.70B and $83.37M in sales. Profit margin for the company is -180.00%. Distance from 52-week low is 226.73% and -4.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.34%).
The EPS is expected to grow by 17.88% this year
212.0 institutions hold shares in Tarsus Pharmaceuticals Inc (TARS), with institutional investors hold 124.30% of the company’s shares. The shares outstanding are 34.21M, and float is at 31.79M with Short Float at 30.44%. Institutions hold 113.40% of the Float.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 3.41 million shares valued at $92.75 million. The investor’s holdings represent 9.6669 of the TARS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.27 million shares valued at $88.79 million to account for 9.254 of the shares outstanding. The other top investors are PARADIGM BIOCAPITAL ADVISORS LP which holds 2.44 million shares representing 6.8991 and valued at over $66.19 million, while TANG CAPITAL MANAGEMENT LLC holds 6.3874 of the shares totaling 2.25 million with a market value of $61.29 million.
Tarsus Pharmaceuticals Inc (TARS) Insider Activity
The most recent transaction is an insider sale by LINK WILLIAM J PHD, the company’s Director. SEC filings show that LINK WILLIAM J PHD sold 35,000 shares of the company’s common stock on Aug 12 ’24 at a price of $26.08 per share for a total of $0.91 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Jun 18 ’24, Farrow Jeffrey S disposed off 10,445 shares at an average price of $27.47 for $0.29 million. The insider now directly holds 18,136 shares of Tarsus Pharmaceuticals Inc (TARS).
